CytRx , Ben Franklin Technology Partners, Cold Spring Harbor, University of Connecticut, BioScience2004, Regina Elena Cancer Institute, University Hospital Zurich, Eli Lilly, Isis Pharmaceuticals

Nov 28, 2003

Premium

CytRx Subsidary Inks Informatics Deal with 3rd Millenium

CytRx said last week that its subsidiary Araios has signed a deal to establish a computing platform for its development programs with consulting firm 3rd Millennium.

CytRx recently established Araios to use RNAi to validate small molecule drugs for Type II diabetes and obesity. (See RNAi News, 9/19/03).

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

By a Third

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

Faster, Faster

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.